Updated results of a phase II randomized trial with high dose proton pump inhibitors and metronomic capecitabine as salvage treatment for patients with advanced gastrointestinal tumours

被引：0
|
作者：
Roberto, M. [1 ]
Arrivi, G. [2 ]
Milano, A. [1 ]
D'Antonio, C. [1 ]
Romiti, A. [3 ]
Falcone, R. [1 ]
Mazzuca, F. [1 ]
Fais, S. [4 ]
Marchetti, P. [1 ]
机构：
[1] Univ Roma La Sapienza, St Andrea Hosp, Rome, Italy
[2] St Andrea Hosp, Rome, Italy
[3] Univ Roma La Sapienza, St Andrea Hosp, Oncol Dept, Rome, Italy
[4] Ist Super Sanita, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P - 160
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine-A Randomized Phase II Trial
    Markussen, Alice
    Jensen, Lars Henrik
    Diness, Laura Vittrup
    Larsen, Finn Ole
    CANCERS, 2020, 12 (07) : 1 - 10
  • [22] Phase II study of oxaliplatin high-dose capecitabine and sorafenib in patients with advanced pancreatic cancer
    Lubner, S. J.
    Schelman, W. R.
    Mulkerin, D.
    Holen, K. D.
    Seo, S.
    LoConte, N. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: long term results
    Ramón Salazar
    Jaume Capdevila
    Jose Luis Manzano
    Carles Pericay
    Mercedes Martínez-Villacampa
    Carlos López
    Ferrán Losa
    María José Safont
    Auxiliadora Gómez-España
    Vicente Alonso-Orduña
    Pilar Escudero
    Javier Gallego
    Beatriz García-Paredes
    Amalia Palacios
    Sebastiano Biondo
    Cristina Grávalos
    Enrique Aranda
    BMC Cancer, 20
  • [24] Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenocarcinoma: long term results
    Salazar, Ramon
    Capdevila, Jaume
    Luis Manzano, Jose
    Pericay, Carles
    Martinez-Villacampa, Mercedes
    Lopez, Carlos
    Losa, Ferran
    Jose Safont, Maria
    Gomez-Espana, Auxiliadora
    Alonso-Orduna, Vicente
    Escudero, Pilar
    Gallego, Javier
    Garcia-Paredes, Beatriz
    Palacios, Amalia
    Biondo, Sebastiano
    Gravalos, Cristina
    Aranda, Enrique
    BMC CANCER, 2020, 20 (01)
  • [25] Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial
    Smith, David C.
    Smith, Matthew R.
    Sweeney, Christopher
    Elfiky, Aymen A.
    Logothetis, Christopher
    Corn, Paul G.
    Vogelzang, Nicholas J.
    Small, Eric J.
    Harzstark, Andrea L.
    Gordon, Michael S.
    Vaishampayan, Ulka N.
    Haas, Naomi B.
    Spira, Alexander I.
    Lara, Primo N., Jr.
    Lin, Chia-Chi
    Srinivas, Sandy
    Sella, Avishay
    Schoeffski, Patrick
    Scheffold, Christian
    Weitzman, Aaron L.
    Hussain, Maha
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04) : 412 - 419
  • [26] Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomized phase II study
    Rosati, G.
    Cordio, S.
    Bordonaro, R.
    Caputo, G.
    Novello, G.
    Reggiardo, G.
    Manzione, L.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 781 - 786
  • [27] A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours
    Ang, Yvonne L. E.
    Ho, Gwo Fuang
    Soo, Ross A.
    Sundar, Raghav
    Tan, Sing Huang
    Yong, Wei Peng
    Ow, Samuel G. W.
    Lim, Joline S. J.
    Chong, Wan Qin
    Soe, Phyu Pyar
    Tai, Choo
    Wang, Lingzhi
    Goh, Boon Cher
    Lee, Soo-Chin
    BMC CANCER, 2020, 20 (01)
  • [28] A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours
    Yvonne L. E. Ang
    Gwo Fuang Ho
    Ross A. Soo
    Raghav Sundar
    Sing Huang Tan
    Wei Peng Yong
    Samuel G. W. Ow
    Joline S. J. Lim
    Wan Qin Chong
    Phyu Pyar Soe
    Bee Choo Tai
    Lingzhi Wang
    Boon Cher Goh
    Soo-Chin Lee
    BMC Cancer, 20
  • [29] Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial
    Kornek, GV
    Schuell, B
    Laengle, F
    Gruenberger, T
    Penz, M
    Karall, K
    Depisch, D
    Lang, F
    Scheithauer, W
    ANNALS OF ONCOLOGY, 2004, 15 (03) : 478 - 483
  • [30] A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours
    Pico, JL
    Rosti, G
    Kramar, A
    Wandt, H
    Koza, V
    Salvioni, R
    Theodore, C
    Lelli, G
    Siegert, W
    Horwich, A
    Marangolo, M
    Linkesch, W
    Pizzocaro, G
    Schmoll, HJ
    Bouzy, J
    Droz, JP
    Biron, P
    ANNALS OF ONCOLOGY, 2005, 16 (07) : 1152 - 1159
12345